ArticleVirus research2022

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.

Mohsen Abdoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.